Posts in the “ALK ALK” category:

Detecting and Treating ALK-Positive Lung Cancers

Posted by Samantha Powell on August 26th, 2014 |

Hello. This is Mark Kris, from Memorial Sloan Kettering Cancer Center in New York City. I want to spend a few minutes talking about the treatment of ALK-positive lung cancers and ROS1, another of the oncogene fusion-driven lung cancers. We have had some recent data come out. I think the first piece to discuss is […]

Lung Cancer Alliance praises NCI’s new ALCHEMIST trial

Posted by Samantha Powell on August 19th, 2014 |

Lung Cancer Alliance (LCA) President & CEO, Laurie Fenton Ambrose praised the National Cancer Institute’s (NCI) new trial, launched today, that will focus on the prevention of recurrence in two specific types of lung cancers when they are caught at early stage and surgically removed. “This trial demonstrates the power of CT screening to open […]

GRACE gathered experts in ALK positive lung cancer to lead a patient forum

Posted by Samantha Powell on February 1st, 2014 |

In February 2014, GRACE gathered experts in ALK positive lung cancer to lead a patient forum. Speakers were Dr. Alice Shaw, Dr. Ross Camidge, Dr. Jared Weiss, and Dr. Jack West. ALK Rearrangements in Lung Cancer – 12:28 The doctors discuss the history of ALK in lung cancer treatments and what the ALK rearrangement means […]

Targeted Treatment Better than Chemo in Some Lung Cancers

Posted by Samantha Powell on January 13th, 2014 |

Date: 1/13/14 Outlet Full Name: Drug Discovery & Development Author: No author http://www.dddmag.com/news/2014/01/targeted-treatment-better-chemo-some-lung-cancers Patients with lung cancer who also have a specific gene rearrangement do better on a new targeted therapy compared with standard chemotherapy, according to a study by academics from the Manchester Cancer Research Centre (MCRC). Around 2 percent of patients with non-small […]